The product was distributed without FDA authorization or clearance for marketing and distribution in the US.
Source facts
Action
The firm initially contacted affected customers by phone between March 4 and March 12, 2022. On March 21, 2022, the firm followed up with emails to each affected distributor with subject line "IMPORTANT!!! Recall Notice" which included a recall letter attachment. Customers were asked to immediately return all unused product. The firm sent an additional email on March 25, 2022 which instructed customers to not rely on the recalled tests to make medical decisions.
As of April 9, 2022, the full recall notice can be found at www.smldistribution.com.
Initiated
2022-03-04
Root cause
No Marketing Application
Distribution
US Nationwide distribution in the states of AL, FL, GA, MO, NY, TX, and WY.
Recall number
Z-0944-2022
Recall status
Open, Classified
CDRH record ID
193010
FDA record created
2022-05-03
Recall event number
89975
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.